PHARMAC's updated guidelines for cost-utility analyses, with new QALYs per $1M metric

N Z Med J. 2012 Jul 29;125(1358):89-90.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cost-Benefit Analysis
  • Drug Costs*
  • Humans
  • Models, Econometric
  • National Health Programs / economics*
  • New Zealand
  • Outcome Assessment, Health Care / economics
  • Outcome Assessment, Health Care / methods*
  • Pharmaceutical Services / economics*
  • Quality-Adjusted Life Years*